Cargando…
Correction: Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells—an in‑vitro study
Autores principales: | Brunner, Teresa F., Probst, Florian A., Troeltzsch, Matthias, Schwenk‑Zieger, Sabina, Zimmermann, Julia L., Morfill, Gregor, Becker, Sven, Harréus, Ulrich, Welz, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436649/ https://www.ncbi.nlm.nih.gov/pubmed/37596585 http://dx.doi.org/10.1186/s13005-023-00386-x |
Ejemplares similares
-
Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells—an in-vitro study
por: Brunner, Teresa F., et al.
Publicado: (2022) -
Cold Atmospheric Plasma: A Promising Complementary Therapy for Squamous Head and Neck Cancer
por: Welz, Christian, et al.
Publicado: (2015) -
Restoration of Sensitivity in Chemo — Resistant Glioma Cells by Cold Atmospheric Plasma
por: Köritzer, Julia, et al.
Publicado: (2013) -
Decolonisation of MRSA, S. aureus and E. coli by Cold-Atmospheric Plasma Using a Porcine Skin Model In Vitro
por: Maisch, Tim, et al.
Publicado: (2012) -
Cold atmospheric plasma for local infection control and subsequent pain reduction in a patient with chronic post-operative ear infection
por: Isbary, G, et al.
Publicado: (2013)